XGN logo

Exagen (XGN) Shareholders Equity

Annual Shareholders Equity

$22.69 M
-$19.77 M-46.55%

December 31, 2023


Summary


Performance

XGN Shareholders Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherXGNbalance sheetmetrics:

Quarterly Shareholders Equity

$12.87 M
-$4.72 M-26.82%

September 30, 2024


Summary


Performance

XGN Quarterly Shareholders Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherXGNbalance sheetmetrics:

Shareholders Equity Formula

Shareholders Equity = Total Assets − Total Liabilities

XGN Shareholders Equity Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-46.5%-53.2%
3 y3 years-45.8%-85.8%
5 y5 years+437.0%-71.1%

XGN Shareholders Equity Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-73.3%at low-84.8%at low
5 y5-year-73.3%at low-87.3%at low
alltimeall time-73.3%+202.3%-87.3%+158.0%

Exagen Shareholders Equity History

DateAnnualQuarterly
Sep 2024
-
$12.87 M(-26.8%)
Jun 2024
-
$17.59 M(-12.0%)
Mar 2024
-
$19.99 M(-11.9%)
Dec 2023
$22.69 M(-46.6%)
$22.69 M(-17.5%)
Sep 2023
-
$27.50 M(-13.8%)
Jun 2023
-
$31.90 M(-11.2%)
Mar 2023
-
$35.94 M(-15.4%)
Dec 2022
$42.46 M(-50.0%)
$42.46 M(-24.4%)
Sep 2022
-
$56.19 M(-12.5%)
Jun 2022
-
$64.18 M(-15.7%)
Mar 2022
-
$76.16 M(-10.3%)
Dec 2021
$84.94 M(+103.0%)
$84.94 M(-6.5%)
Sep 2021
-
$90.80 M(-5.8%)
Jun 2021
-
$96.38 M(-5.0%)
Mar 2021
-
$101.47 M(+142.5%)
Dec 2020
$41.84 M
$41.84 M(-5.9%)
DateAnnualQuarterly
Sep 2020
-
$44.47 M(-7.0%)
Jun 2020
-
$47.84 M(-5.3%)
Mar 2020
-
$50.54 M(-9.2%)
Dec 2019
$55.66 M(-926.5%)
$55.66 M(-5.1%)
Sep 2019
-
$58.65 M(-8383.9%)
Jun 2019
-
-$708.00 K(-89.5%)
Dec 2018
-$6.73 M(+45.2%)
-$6.73 M(-69.6%)
Dec 2017
-$4.64 M(-79.1%)
-
Dec 2015
-$22.18 M(+57.8%)
-$22.18 M(+19.2%)
Sep 2015
-
-$18.61 M(+18.9%)
Jun 2015
-
-$15.64 M(-8.4%)
Mar 2015
-
-$17.08 M(+21.5%)
Dec 2014
-$14.06 M(-3216.6%)
-$14.06 M(+20.6%)
Sep 2014
-
-$11.65 M(+65.1%)
Jun 2014
-
-$7.05 M(-1664.3%)
Dec 2013
$451.00 K(-90.6%)
$451.00 K
Dec 2012
$4.82 M
-

FAQ

  • What is Exagen annual stockholders equity?
  • What is the all time high annual shareholders equity for Exagen?
  • What is Exagen annual shareholders equity year-on-year change?
  • What is Exagen quarterly stockholders equity?
  • What is the all time high quarterly shareholders equity for Exagen?
  • What is Exagen quarterly shareholders equity year-on-year change?

What is Exagen annual stockholders equity?

The current annual shareholders equity of XGN is $22.69 M

What is the all time high annual shareholders equity for Exagen?

Exagen all-time high annual stockholders equity is $84.94 M

What is Exagen annual shareholders equity year-on-year change?

Over the past year, XGN annual stockholders equity has changed by -$19.77 M (-46.55%)

What is Exagen quarterly stockholders equity?

The current quarterly shareholders equity of XGN is $12.87 M

What is the all time high quarterly shareholders equity for Exagen?

Exagen all-time high quarterly stockholders equity is $101.47 M

What is Exagen quarterly shareholders equity year-on-year change?

Over the past year, XGN quarterly stockholders equity has changed by -$14.64 M (-53.21%)